WO2013131816A1 - Formalinfreie fixierungsmittel für histologische färbungen von gewebeproben - Google Patents
Formalinfreie fixierungsmittel für histologische färbungen von gewebeproben Download PDFInfo
- Publication number
- WO2013131816A1 WO2013131816A1 PCT/EP2013/054146 EP2013054146W WO2013131816A1 WO 2013131816 A1 WO2013131816 A1 WO 2013131816A1 EP 2013054146 W EP2013054146 W EP 2013054146W WO 2013131816 A1 WO2013131816 A1 WO 2013131816A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- tissue
- staining
- solution
- fixing agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/36—Embedding or analogous mounting of samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
Definitions
- the invention relates to a development of a fixative solution which brings about a clear improvement of the known histological and immunological staining techniques as well as the staining techniques used in pathology.
- the present invention improves the quality and staining of tissue samples that have not been fixed with formalin.
- the present invention for sensitive, difficult to cut at Formalinfix ist tissue that can be cut not only in better quality without artifacts, but also have higher brilliance and color stability in the dyeing.
- Organism usually taken irish, or whole organs or whole animals /
- fixation serves to fix the state of the tissue at the time of removal in order to examine and / or stain this state directly at a later time directly microscopically and then to differentiate the stained cell or tissue parts microscopically on the basis of their chemical properties and thus to investigate or make diagnoses.
- tissue fixation the tissue piece or organ or the whole organism is impregnated via its vascular system with the fixing solution, it is called Perfussions- or
- the tissue sample may be embedded in paraffin, for example
- the sample is usually in an alcohol series with ascending
- a paraffin block can be stored practically indefinitely at room temperature conditions or slightly cooled, that is, for example, individual sections can be created, the block can then be stored again and stored for later further processing.
- Such thin sections are usually grown on glass slides and then gem. stained with special instructions (so-called histological staining protocols or staining protocols). Only by staining it becomes possible to differentiate differences in tissue structure microscopically, to differentiate pathological from healthy tissue and diagnostic
- the dyes used bind specifically to certain structures or chemical components of the tissue structures, and thus specific, i. E. Colorize depending on their chemistry.
- Cell nuclei clearly differentiate from the cytoplasm, different cell types are stained differently, as are fibers and other tissue components. The overall picture of a staining then allows a diagnostic assessment of the examined tissues.
- fixatives In addition to formalin, many other fixatives based on methanol, ethanol, acetic acid, chloroform, chlorohydrate, picric acid, mercury dichloride, potassium dichromate, chromic acid, osmium tetroxide and various salt solutions and salt mixtures have been and still are used in histology. However, all these fixatives are not universal, but only in each case specifically for certain types of tissue, certain issues and further processing suitable. There is a direct correlation between fixation (fixative), tissue preservation and the result of the staining, which can finally be evaluated in the microscope.
- Polymerization added to the commercial formalin solution may adversely affect the results of histological staining, as they are dehydrating, similar to ethanol, and interfere with some dye-tissue compounds.
- Formalin plays a central role. Here it will be i.d.R. but not used as “4% formalin” but as a “paraformaldehyde solution”.
- Paraformaldehyde (PFA) is the polymerized form of formalin, which is commercially available as a powder and can be completely dissolved in hot, alkaline solution.
- Formalin the aqueous solution of formaldehyde gas
- Formalin has the property of forming in aqueous solution chains of paraformaldehyde, which can precipitate. Furthermore, it decomposes
- Formaldehyde under the action of light, heat and / or oxygen to give formic acid.
- aqueous Formalinlosung permanent degradation and polymerization reactions take place, which as a result, the formaldehyde is continuously degraded. Since there are also regression reactions (depolymerization of the PFA chains, as well as equilibrium reactions), the percentage of formaldehyde in an aqueous solution can never be accurately named.
- Form formaldehyde concentration of 35-37%, sometimes 37-38%.
- Formol is available in different qualities: technical, stabilized and buffered. Hereby these become saturated Formaldehyde solution is added to additives: it is stabilized with methanol (to prevent PFA formation), buffered with calcium carbonate, borax or a phosphate mixture (against lowering the pH upon decomposition to formic acid). Subsequently, a 4% strength formalin solution is prepared from this stock solution by dilution (about 1 + 9), which is therefore not exactly 4%, but rather 3.5-3.9% pure. Some manufacturers offer 4% formalin as "true” 4% formalin, which means that the stock solution is not diluted 1 + 9, but by actual mass percentages.
- a further disadvantage of formalin-fixed pieces of fabric is that they tend to harden on long storage, which negatively affects the cuttability and the dyeability of the fabrics.
- some tissues that have been fixed in formalin are brittle and cracked and difficult or difficult to cut (eg liver, kidney, spleen, musculature, nerve tissue, brain).
- Formalin fixings normal. This leads to tissue cracks and also to one or the other misinterpretation of the extent and size of certain structures.
- Frozen section Here, the fixation of the state by immediate freezing after sampling takes place. However, there is no cross-linking of the proteins with each other. The sample is only stable for as long as it is kept at a correspondingly low temperature. In addition, the freezing must be abruptly at very low temperatures (i.d.R. ⁇ -78 ° C), otherwise the formation of water crystals could destroy fine structures of the tissue.
- the "frozen section" is the so-called quick cut and is produced i.d.R only for special applications, for example, where there is no time to wait for the chemical fixation reaction (e.g.
- the fixation of a tissue sample is a necessary step to ensure a permanent and longer-term preservation.
- the invention provides a formalin-free solution which is suitable for fixing tissue samples of all kinds and for improving the dyeability of the samples.
- the solution according to the invention is characterized by the fact that a total aldehyde concentration of at least 0.5 mol / l, but if necessary also significantly more, can be released by the present acid in the composition according to the invention.
- At least one polyamine selected from the group consisting of urotropin, triazines, mono-, di-, tri-, tetra-, penta- or hexamethylolmelamine, dimethylol-dihydroxyethylenurea, tetramethylol-acetylenediurea, dimethylol-propylenurea, acetoguanamine or 5.5- Dimethylhydantoin and mixtures thereof, and
- At least one acidifying agent selected from the group of the free di- or polybasic acid consisting of oxalic acid, fumaric acid, tartaric acid, maleic acid, succinic acid, hydrochloric acid, acetic acid, propionic acid, formic acid, mono-, di-, tri-, chloroacetic acid, boric acid,
- Phosphoric acid or mixtures thereof characterized in that the polyamine reacts with the protons released by the acid and thereby forms aldehydes.
- the molar ratio between the concentration of the maximum releasable aldehydes in moles and the concentration of the maximum releasable protons in moles in the solution according to the invention is 1: 0.7 to 1: 1.5, preferably 1: 0.7 to 1: 0 , 9, more preferably 1: 0.8 to 1: 1, more preferably 1: 0.9 to 1: 1, 2, further preferably 1: 1 to 1: 1.4 and / or more preferably 1: 1.2 to 1: 1, 5 and is thus chosen so that a ratio of at least 0.5 and a maximum of 2 is established between 'total releasable aldehyde' and 'total of the acid-releasable protons',
- the solution according to the invention is characterized in that the solution comprises at least one further polymn Dictionaryelles aldehyde selected from the group consisting of citral, 3,7-dimethylocta-2,6 ⁇ dienal, geranial, (E) -3,7- Dimethyl octa-2,6-dienal, propanal, butanal,
- chemical functional groups may be selected from the following: aryl group, whether phenyl, naphthyl, thienyl, indolyl, etc, linear or amylated akyl, alkenyl or alkyne groups as well as corresponding halogenated groups; - oxygenated groups hydroxil, carbonyl, aldehyde, haloformyl, carbonate ester, carboxilate, carboxy, ester, hydroxiperoxy, hydroxy, ether; Groups with nitrogen, e.g.
- multifunctional aldehydes because they can bind to one another by their aldehyde function at various points of the sample via various chemical mechanisms and offer via their other bound and supported chemical functions docking sites for the dyes used, which are used for staining the sample.
- polyfunctional aldehydes therefore, additional chemical functional groups are bound to the tissue sample during the tissue fixation step.
- the chemical functions of the multifunctional aldehydes are chosen so that certain types of dyes are better bound than others or even chosen such that certain Types of dyes interfere with the binding to the sample or attenuated.
- a spatial differentiation of the dyeability of the sample is achieved.
- control mechanism achieved in this way is an advantage of the invention with which the color contrast of the sample is additionally controlled by the addition of the multifunctional aldehydes, because by binding these functional groups to the tissue sample additional docking sites and reaction sites for the molecules of the dyes are provided, so that an optimal Coloring is not only achievable in a shorter time, but in particular a higher color intensity, brilliance and / or contrast can be achieved.
- Composition is carried out in the examples.
- the molar concentration of the total available aldehyde in the solution according to the invention, which is formed from the polyamine together with the acid, or which is produced by the polyfunctional aldehyde, in the solution according to the invention is preferably at least 0.5 mol / l , preferably 0.6-0.69 mol / l, more preferably 0.7-0.79 mol / l, more preferably 0.8-0.89 mol / l, further preferably 0.9-0.99 mol / 1, more preferably 0.99 to 1, 2 mol / 1 set.
- a surfactant which is selected from the group containing ethoxylated nonionic surfactants with high and / or low HLB value, polysorbates especially polysorbate 20, 40, 60 or 80, saponins, alkali metal salts of Dccilsulphate, Decilsulphonate, Dodecilsulfate , Dodecyl sulphonates, dodecylbenzenesulphonates, oleates, stearates, caprates, caprilates and betaines.
- organic or inorganic salts selected from the group of lithium, sodium, potassium, calcium, strontium / chlorides, sulphates, acetates, citrates, nitrates, succinates and / or formates.
- organic or inorganic thickeners selected from the group consisting of carbomers, starch and modified starch, agarose, dextrose, methyl, ethyl or propyl zeolite, acrylic acid and PVA.
- the notified solution is in aqueous form.
- the components of the notified solution are provided as an anhydrous mixture of crystalline and / or anhydrous components, which are provided in the form of soluble powder or as a soluble, compressed tablet.
- This powder or tablet is dissolved by the addition of water or other suitable solvent or mixture thereof to provide a ready-to-use fixing solution.
- An advantage of the solution according to the invention is also its pH stability.
- the solution according to the invention is stable in pH ranges of pH 3-8, preferably pH 3-6. This stability is achieved by adjusting the molar ratio of the amine group to the acid groups in one
- This pH stability is based on the strong buffering capacity of the polyamines, which usually react slightly alkaline.
- the polyamine e.g. Urotropin with the proton of the acid (e.g., citric acid) forms an aldehyde and the corresponding ammonium salt.
- This establishes an equilibrium, which is influenced by the dissociation constant of the acid and the hydrolysis constant of the polyamine and thereby regulates the pH to a certain level - at about pH 4 to pH 8.
- 1 mole of urotropin can consume 6 moles of protons, thus even small amounts of urotropin or polyamines buffer large amounts of acid and thus maintain the pH of the solution at a constant level.
- a further advantage of the solution according to the invention is the color brilliance and color intensity of the samples fixed with the solution according to the invention.
- exemplary embodiments 4-5 show a marked improvement in the morphological preservation and cuttability of the fixed samples for the fixations carried out by way of example.
- the stains performed namely hematoxylin & eosin, Masson Goidner trichrome, MSB-Lendrum and azan according to Geidies, described in Examples 4 and 5, show that by using the fixative solution according to the invention a marked improvement in dyeability in general and in particular in color saturation and the color brilliance is achieved.
- many difficult-to-manipulate tissues, such as brain, skin and testicles are much better to cut and stain with the new fixation.
- HOPE fixation Hepes-Glutamic acid buffer mediated Organic Solvent Protection Effect
- this fixation can be carried out only in a complex equipment and with a complex processing procedure, so that they are difficult for the daily Routine is suitable.
- the solution according to the invention fulfills these requirements and for the first time allows the fixation and staining of tissue samples fixed in formalin-free form and even marked improvement in color saturation, color brilliance and color intensity in the following enumerated procedures: a) hematoxylin & eosin staining, using different
- Hematoxylin solutions (according to Mayer, Gill, Harris, Weigert, Verhoff, Hansen, etc.) and eosin solutions (in aqueous, alcoholic or methanolic form with various concentrations and additions of acetic acid or other pH-lowering additives).
- eosin solutions in aqueous, alcoholic or methanolic form with various concentrations and additions of acetic acid or other pH-lowering additives.
- trichrome staining such as Masson, Masson-Goldner, Azan,
- Cell nuclei plasma components and chemical properties, such as elastica Dyeings, proofs of aldehydes, iron certificates, other metal detections,
- the invention improves the plastic properties of the fixed material, so that in the
- a weathering advantage of the inventive solution is the fact that tissue samples fixed with this solution have excellent cutting properties, and those tissues which, when fixed with formaldehyde-containing solutions, are difficult to cut (eg, brain tissue), it comes to significant improvements in cutting properties.
- tissue preservation is advantageous. Shrinkage hardly occurs, and if so, to a much lesser extent than with formalin fixations. Cell nuclei retain their round shape and can be dyed very well with common nuclear dyes. Up into the finest structures is to observe an excellent preservation, which even equals the preservation of fixations with sublimate and picric acid-containing fixatives.
- the fixing times correspond to those of formalin. Longer fixations are unproblematic, or even advantageous. In no case, however, is an undesired over-fixation of the tissue observed during treatment with the solution according to the invention. Furthermore, the notified solution is safe from hazardous substances and hazardous to the eyes and can also be handled during disposal, such as harmless chemical waste.
- the invention also relates to the use of the solution as a preservative for macroscopic preparations, with below whole carcasses or corpses, as used in the anatomy teaching. In addition, it is also used for the fixation and permanent conservation of biological specimens in natural history museums, zoological or botanical collections, research collections and educational collections.
- the invention also relates to the use of the fixative for
- Figure 1 shows a comparison of staining results of AZAN staining on a tissue sample, namely cerebellum rat, wherein the sample used for Figure 1 A with formalin 4%, was fixed according to standard methods and the sample used for Figure 1B in
- Figure 1 B has fewer cracks, shows better preservation of the preparation and the neurons and assumes a stronger coloration.
- Figure 2 shows a comparison of staining results of a HEMATOXYLIN & EOSIN (H & E) staining on a tissue sample, namely testes rat, wherein the sample used for Figure 2A with formalin 4%, was fixed according to standard procedures and the sample used for Figure 2B in the identical procedure but was fixed with the inventive solution. It can clearly be seen that FIG. 2B has clearer structures, fine structures are better preserved, and that the sample assumes a stronger coloration.
- Figure 3 shows a comparison of staining results of a MSB LENDRUM staining on a tissue sample, namely testes rat, wherein the sample used for Figure 3A with formalin 4%, was fixed according to standard procedures and the sample used for Figure 3B in
- Figure 4 shows a comparison of staining results of a MOVAT staining on a tissue sample, namely lung rat, wherein the sample used for Figure 4A with formalin 4%, was fixed according to standard procedures and the sample used for Figure 4B in the identical method, however, with the inventive solution was fixed. It can clearly be seen that FIG. 4B has clearly delimited structures, fine structures (bronchi and aviols) are better preserved, and that the sample assumes a stronger coloration.
- Figure 5 shows a comparison of staining results of a MASSON TRICHROM staining on a tissue sample, namely tongue rat, wherein the sample used for Figure 5A with
- FIG. 5B has a sharper differentiation of the fine structures, the coloration leads to stronger colored cell nuclei and the sample as a whole assumes a stronger coloration.
- Example 1 Composition and Components of a Fixative
- Citric acid calculates the molar ratio as follows:
- Urotropin releases up to 6 moles of formaldehyde from 1 mole of urotropin.
- Citric acid releases up to 3 moles of protons for 1 mole of citric acid.
- a solution containing 4% urotropin and 5.5% citric acid (as suggested in this Example 1) thus achieves a molar urotropin concentration of 0.28 M and can form up to a maximum of 1.71 M formaldehyde. Furthermore, the molar concentration of citric acid is 0.28 M and can form a maximum of 0.85 M protons.
- a known solution containing 1% hexamethylenetetramine (HMTA) and 1% citric acid has, after appropriate calculation as in Example 1.1.
- the molar concentration of citric acid is here at 0.052M and can form a maximum of 0.15 ⁇ M protons.
- Example 2 Composition and components of another preferred embodiment
- HMM H-methylolmelamine
- HMM 1 mole of HMM contains 6 moles of aldehyde or 180 g
- the present composition has a ratio of total releasable aldehyde / total releasable protons of about 1: 1.
- any combination of the substances indicated under position 1 with the substances from position 2 can be displayed.
- the substances from position 5 are combined, e.g. to adjust the proportion of total-releasable aldehyde.
- a solution composed by these combinations must have at least 0.5 mol / 1 of total releasable aldehyde.
- Substance alternatives of positions 3 and 4 as well as 6 and 7 are optional and can be combined as required.
- Formic acid mono-, di-, tri-, chloroacetic, uric, citric, boric, phosphoric, or mixtures thereof
- TWEEN 80 polysorbates 20, 40, 60 or 80, alkalines, lauryl sulfates;
- High HLB ionic and nonionic surfactants hydrophobic-lipophilic-balance describes the hydrophilic and lipophilic content of mainly non-ionic surfactants in chemistry and was proposed by WC Griffin in 1954. Surfactants with a high HLB value cause a good wetting of hydrophilic surfaces) or mixtures thereof
- Example 4 Method for preparation of histological samples for microscopic examination.
- the tissue sample should be as fresh as possible in the fixative solution e.g. the solution according to Example 1, are brought. It is generally customary that the amount of the fixing solution corresponds to twenty times the sample volume and the fixing time is dependent on the sample size. Depending on their size, the samples will last from 12 to 36 hours, larger samples will remain in the fixative solution for 72 hours or longer. You go from one
- the sample is taken out of the fixing solution, washed in running water and dipped in ascending concentration in a number of alcohols.
- the steps between the concentration steps are here eg 30-50 ⁇ 60-70-80-90-96-100.
- alcohols usually ethanol or isopropanol are used.
- the sample is immersed in a suitable organic solvent which is miscible with both alcohol and the embedding medium, followed by infiltration with the actual embedding medium (paraffin) in several stages, for several hours each (depending on the sample size).
- the sample is poured into a suitable mold with a small amount of paraffin. After the block is solidified, the block is removed from the mold and can then be cut.
- a suitable Microtome sections are made in the thickness of 4-6 ⁇ and this mounted on glass slides.
- the glass slides with the paraffin sections can be stored for a long time. l.d.R. however, there is a direct further processing, i. Coloring.
- the paraffin must first be removed again and the tissue section itself should be watered.
- the procedure described above is applied in reverse order, i. Dissolve the paraffin with xylene, then alcohol 96%, 90%, 80%, 70%, o. ⁇ . a similar sequence, down to the water. Only then does the staining begin, whereby in the case of dyes which are present in alcoholic solution, the steps until complete washing can be dispensed with and the slides are dipped directly into the alcoholic staining solution.
- Example 5 Assessment of the morphological conservation, cutting and dyeability of
- a diagnostic evaluation of cut samples could be carried out.
- the sections were made from tissues previously fixed in either the solution of Example 1 or in 4% formalin.
- the qualitative evaluation was carried out on four exemplarily selected stains (1) hematoxylin & eosin (HE), (2) azan according to Geidies, (3) Masson Goldner Trich.ro m and (4) MSB Lendrum.
- the histological diagnostic evaluation records the parameters Morphological Conservation and
- HEMATOXYLIN & EOSIN The classic H & E staining uses the hematoxylin dyes in the Mayer and Eosin composition. Both dyes are offered in aqueous solution (eosin possibly also as alcoholic solution) with a defined pH or a defined acid addition and provide a characteristic staining image. Cell nuclei usually stain blue-violet here.
- the dye hematoxylin which is offered as an alum complex, reacts with the chromatin of the cell nuclei. In order to obtain a stable, water- and alcohol-insoluble paint this compound is then immersed in tap water or in a mixed with monovalent metal ions salt solution.
- the eosin solution is adjusted to a pH of about 4.0 in aqueous form resulting in a characteristically bright orange color image leads. Eosin binds with varying intensity to different tissue and cell structures and thus allows a good differentiation of the histological section.
- MASSON GOLDNER TRICHROM The Masson Goldner trichrome and the Crossmon stain are also classical histological stains that work as a trichrome stain with three (or four) stains.
- the nuclei are also stained with hematoxylin, but not with an alum complex, but via an iron complex. This does not lead to a blue-violet-colored nucleus, but to a brown-black nucleus, which can be differentiated very clearly against blue-colored tissue components.
- a second dye a mixture of acid fuchsin, poneeau and azophloxin is used, which binds in different ways to different tissue areas and allows cytoplasm and others
- the fourth dye is alternatively aniline blue or
- MSB-LENDRU The MSB-Lendrum staining is a coloration related to the Masson Goldner trichrome, but instead of the acid fuchsin-azophloxin-ponceau and instead of orange G the dyes Martiusgelb and Kristallponceau are offered.
- the result is a comparable, but still more differentiated picture to observe, with the significance of MSB staining is particularly valuable for vascular structures, because here muscle strands, fiber arrangement and vessel walls are better differentiated than in the aforementioned
- AZAN AFTER GEIDIES The AZAN coloring also belongs to the series of the classical ones
- the result of the staining is so similar that the classical AZAN staining can be largely replaced.
- the results are essentially similar to those of K asson-Goldner and MSB-Lendrum.
- Nuclei are stained strongly red by the seed red powder offered in aluminum sulphate solution and stand out well against the continuous blue background.
- Aniline blue and organ G produce the counter- or background staining (blue) and a well differentiated staining of the erythrocytes (orange) and the muscle piasm (also strong orange).
- creatine, keratinized epithelia also turn to orange. Ground substance and fibers get different shades of blue due to the aniline blue. Overall, the result of aniline blue staining is strongly influenced by the pickling time.
- the following parameters can be used to assess the morphological conservation on the light microscopic level, (A) fragmentation of the tissue (cracking) and (B) the representation of the nuclei (nuclei) and (C) of the cell bodies (Somata).
- the fragmentation of the tissue by the formation of individual cracks or spread nets results from a poor fixation and manifests itself in the stretching of the tissue section on the hot water bath or the heating plate and during the dyeing process.
- the heat-related stretching of the paraffin and thus also of the paraffin-permeated and enveloped tissue section, there is a physical load on the paraffin / tissue dressing, which may result in lack of fixation in the rupture of the tissue.
- the tensile or tension forces occurring during dewaxing and staining of the tissue section are particularly pronounced on, stretched or completely ruptured tissue during stretching.
- the tendency to crack is proportional to the adhesive property of the slide used.
- a tissue can be fixed by fixation e.g. brittle and brittle (no cuttability, 4) or supple and resistant (high cuttability, 1). Different tissue properties of different tissue types must be considered in the assessment.
- Histological staining of tissue sections often allows manifold distinctions between individual cells as well as tissue types.
- This histological differential diagnosis which is used in human and veterinary diagnostics but also in medical, zoological and botanical research, is based on the differentiation of cell nucleus types, but in particular also on the differentiation of color precipitates on cells or tissues.
- the highest possible color saturation, uniform color precipitation, good contrast (between nucleus and cell body) and a high level of color saturation Color brilliance are therefore not only desirable, but also urgently required requirements for coloring.
- Various fixatives may, depending on the incubation time, improve or even reduce the dyeability of a tissue section.
- the following criteria are used: 1. Color saturation, 2. Uniform color precipitation, 3. Contrast between cell nucleus and cell body and 4. Color brilliance.
- the individual dyeings must be evaluated separately, since dyeings or their components react differently to the influence of fixing agents.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Description
Claims
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2865584A CA2865584A1 (en) | 2012-03-06 | 2013-03-01 | Formalin-free fixation agent for histological stains of tissue samples |
| EP13712493.9A EP2823282B1 (de) | 2012-03-06 | 2013-03-01 | Formalinfreie fixierungsmittel für histologische färbungen von gewebeproben |
| AU2013229654A AU2013229654B2 (en) | 2012-03-06 | 2013-03-01 | Formalin-free fixation agent for histological stains of tissue samples |
| ES13712493.9T ES2657487T3 (es) | 2012-03-06 | 2013-03-01 | Agentes de fijación exentos de formalina para tinciones histológicas de muestras de tejidos |
| US14/383,332 US9562836B2 (en) | 2012-03-06 | 2013-03-01 | Formalin-free fixation agent for histological stains of tissue samples |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102012101896.0 | 2012-03-06 | ||
| DE102012101896A DE102012101896A1 (de) | 2012-03-06 | 2012-03-06 | Formalinfreie Fixierungsmittel für histologische Färbungen von Gewebeproben |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2013131816A1 true WO2013131816A1 (de) | 2013-09-12 |
Family
ID=47998392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2013/054146 Ceased WO2013131816A1 (de) | 2012-03-06 | 2013-03-01 | Formalinfreie fixierungsmittel für histologische färbungen von gewebeproben |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9562836B2 (de) |
| EP (1) | EP2823282B1 (de) |
| AU (1) | AU2013229654B2 (de) |
| CA (1) | CA2865584A1 (de) |
| DE (1) | DE102012101896A1 (de) |
| ES (1) | ES2657487T3 (de) |
| WO (1) | WO2013131816A1 (de) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9562836B2 (en) | 2012-03-06 | 2017-02-07 | Roberto Gerigk | Formalin-free fixation agent for histological stains of tissue samples |
| EP4145105A1 (de) | 2021-09-06 | 2023-03-08 | Anacyte Laboratories GmbH | Lösung für die asservierung von zellen |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102013223384B4 (de) * | 2013-11-15 | 2015-05-28 | Leica Biosystems Nussloch Gmbh | Fixierung von Gewebeproben unter Verwendung Aldehyde freisetzender stickstoffhaltiger Verbindungen |
| CN106415234A (zh) * | 2014-05-28 | 2017-02-15 | 凯杰有限公司 | 用于含细胞液体样品的固定剂组合物 |
| WO2017083729A2 (en) | 2015-11-13 | 2017-05-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Fixatives and methods of use |
| DE102016102346A1 (de) | 2016-02-10 | 2017-08-10 | Biosepar Gesellschaft für Medizin- und Labortechnik mbH | Fixativum |
| CN110864957A (zh) * | 2019-11-18 | 2020-03-06 | 安徽雷根生物技术有限公司 | 一种不含甲醛的组织固定方法 |
| CN113588383B (zh) * | 2021-06-15 | 2024-07-02 | 北京清华长庚医院 | 一种肝脏病理大切片的he染色方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994004906A1 (en) * | 1992-08-12 | 1994-03-03 | Biogenex Laboratories | Enhancement of immunochemical staining in aldehyde-fixed tissues |
| WO1994007532A1 (en) * | 1992-09-10 | 1994-04-14 | Streck Laboratories, Inc. | Method and composition for preserving antigens and process for utilizing cytological material produced by same |
| WO1997039330A1 (en) * | 1996-04-12 | 1997-10-23 | Oncor, Inc. | Method and composition for controlling formaldehyde fixation by delayed quenching |
| US6072086A (en) * | 1996-04-12 | 2000-06-06 | Intergen Company | Method and composition for controlling formaldehyde fixation by delayed quenching |
| US20100209930A1 (en) * | 2009-02-18 | 2010-08-19 | Streck, Inc. | Preservation of cell-free nucleic acids |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5196182A (en) * | 1991-05-08 | 1993-03-23 | Streck Laboratories, Inc. | Tissue fixative |
| US5849517A (en) * | 1991-05-08 | 1998-12-15 | Streck Laboratories, Inc. | Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same |
| DE102006040315B4 (de) | 2006-08-29 | 2008-06-05 | Biosepar -Gesellschaft für Medizin- und Labortechnik mbH | Fixativum zum Fixieren von biologischen Materialien |
| DE102012101896A1 (de) | 2012-03-06 | 2013-09-12 | Roberto Gerigk | Formalinfreie Fixierungsmittel für histologische Färbungen von Gewebeproben |
-
2012
- 2012-03-06 DE DE102012101896A patent/DE102012101896A1/de not_active Withdrawn
-
2013
- 2013-03-01 EP EP13712493.9A patent/EP2823282B1/de not_active Not-in-force
- 2013-03-01 ES ES13712493.9T patent/ES2657487T3/es active Active
- 2013-03-01 US US14/383,332 patent/US9562836B2/en not_active Expired - Fee Related
- 2013-03-01 WO PCT/EP2013/054146 patent/WO2013131816A1/de not_active Ceased
- 2013-03-01 CA CA2865584A patent/CA2865584A1/en not_active Abandoned
- 2013-03-01 AU AU2013229654A patent/AU2013229654B2/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994004906A1 (en) * | 1992-08-12 | 1994-03-03 | Biogenex Laboratories | Enhancement of immunochemical staining in aldehyde-fixed tissues |
| WO1994007532A1 (en) * | 1992-09-10 | 1994-04-14 | Streck Laboratories, Inc. | Method and composition for preserving antigens and process for utilizing cytological material produced by same |
| WO1997039330A1 (en) * | 1996-04-12 | 1997-10-23 | Oncor, Inc. | Method and composition for controlling formaldehyde fixation by delayed quenching |
| US6072086A (en) * | 1996-04-12 | 2000-06-06 | Intergen Company | Method and composition for controlling formaldehyde fixation by delayed quenching |
| US20100209930A1 (en) * | 2009-02-18 | 2010-08-19 | Streck, Inc. | Preservation of cell-free nucleic acids |
Non-Patent Citations (1)
| Title |
|---|
| HISTOLOGICAL TECHNIQUES, LABORATORY MANUAL COLUMBIA UNIVERSITY, 1975 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9562836B2 (en) | 2012-03-06 | 2017-02-07 | Roberto Gerigk | Formalin-free fixation agent for histological stains of tissue samples |
| EP4145105A1 (de) | 2021-09-06 | 2023-03-08 | Anacyte Laboratories GmbH | Lösung für die asservierung von zellen |
| WO2023031467A1 (de) | 2021-09-06 | 2023-03-09 | Anacyte Laboratories Gmbh | Lösung für die asservierung von zellen |
Also Published As
| Publication number | Publication date |
|---|---|
| US9562836B2 (en) | 2017-02-07 |
| EP2823282B1 (de) | 2017-10-25 |
| US20150050689A1 (en) | 2015-02-19 |
| ES2657487T3 (es) | 2018-03-05 |
| DE102012101896A1 (de) | 2013-09-12 |
| CA2865584A1 (en) | 2013-09-12 |
| AU2013229654A1 (en) | 2014-09-25 |
| EP2823282A1 (de) | 2015-01-14 |
| AU2013229654B2 (en) | 2016-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2823282B1 (de) | Formalinfreie fixierungsmittel für histologische färbungen von gewebeproben | |
| DE3873675T2 (de) | Histologischer fixierungsstoff. | |
| DE602004004138T2 (de) | Verfahren zur vorbereitung histologischer proben | |
| DE69133125T2 (de) | Konservierungslösung für Zellen | |
| DE2933438C2 (de) | ||
| EP1969341B1 (de) | Ein verfahren zur behandlung einer biologischen probe | |
| EP0026420B1 (de) | Verfahren und Einbettungssystem zur Einbettung von Gewebsproben | |
| DE60300218T2 (de) | Fixierungslösung | |
| EP2027922A1 (de) | Verfahren und Vorrichtung für das Fixieren/Stabilisieren einer Probe | |
| DE69333586T2 (de) | Verfahren und zusammensetzung zur konservierung von antigenen und verfahren zur verwendung von durch selbiges verfahren hergestellten zytologischem material | |
| DE19928820A1 (de) | Fixiermittel für Zellen und Gewebe von Lebewesen | |
| DE10021390C2 (de) | Protektionslösung und Fixierverfahren für die Paraffinschnitt-Technik | |
| EP1895287B1 (de) | Verwendung von Hexamethylentetramin zum Fixieren von biologischen Materialien | |
| EP3414547B1 (de) | Fixativum | |
| EP3588092B1 (de) | Markierung von alumosilikaten | |
| WO2023031467A1 (de) | Lösung für die asservierung von zellen | |
| EP0459371A1 (de) | Verfahren und Mittel zur Bestimmung der bakteriologischen und zytologischen Beschaffenheit von Rohmilch | |
| DE102022125783A1 (de) | Verfahren zur Aufkonzentrierung mindestens einer anthropogenen Zielsubstanz in einer Probenflüssigkeit | |
| DE830384C (de) | Faerbefluessigkeit zum Faerben von histologischem Gewebe fuer mikroskopische Untersuchungen | |
| DE102024203643A1 (de) | Verfahren und Vorrichtung zur Aufreinigung von Nukleinsäuren, insbesondere für eine Nukleinsäureamplifikation | |
| EP3699572A1 (de) | Inkubationsvorrichtung hergestellt aus einem kompositmaterial und verfahren zum färben einer probe | |
| CN120992276A (zh) | 一种环保型生物组织样本制备套液及其应用 | |
| WO2025201644A1 (de) | Gram-färbemethode | |
| WO2024020615A1 (de) | Lagerstabile zusammensetzung umfassend 4-aminophenol und dessen verwendung bei der bestimmung von cannabinoiden | |
| DE522317C (de) | Fixierungsmittel fuer histologische Zwecke |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13712493 Country of ref document: EP Kind code of ref document: A1 |
|
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
| ENP | Entry into the national phase |
Ref document number: 2865584 Country of ref document: CA |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 14383332 Country of ref document: US |
|
| ENP | Entry into the national phase |
Ref document number: 2013229654 Country of ref document: AU Date of ref document: 20130301 Kind code of ref document: A |
|
| REEP | Request for entry into the european phase |
Ref document number: 2013712493 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2013712493 Country of ref document: EP |



